Table S1. Serum protein levels. All data from the serum analyses are presented. This includes results for all proteins and all samples. (XLSX 64 kb
Complete analysis of cytokine levels in serum and exhaled breath condensate according to the severit...
Table S6. Results from Ingenuity Pathway Analysis Suite Analysis of Biomarker data. (DOCX 18 kb
Panther-based classification of protein pathways comparing lung cancer markers identified in tissues...
Table S1. Quantile regression multivariable analysis of association between COL11A1 and COL10A1 leve...
Additional file 1: Table S1. Differentially expressed proteins identified in plasma samples
Table S1. Protein analyte concentrations for benralizumab- and placebo-treated patients with asthma ...
Demographics and clinical profiles for subjects selected for fresh tissue discovery study
Candidate lung cancer biomarkers (nâ=â179) identified through LC/MS analysis
Figure S1. COL11A and COL10A levels are not associated with overall survival. Kaplan Meier overall s...
Table S1. Serum biomarkers in 2005, comparing subjects participating respectively alive but not part...
Expression levels of biomarker candidates in serum collected from patients with NSCLC (nâ=â94) a...
Panther-based classification of protein class for candidate lung cancer markers (nâ=â179)
S1: baseline characteristics stratified by adverse events. S2-S3: Kaplan-Meier curves for OS and PFS...
Characteristics and differences by serum CYFRA 21-1 levels in patients with advanced-stage lung aden...
Table S2. Datasets of expression levels of complement proteins extracted from published publications...
Complete analysis of cytokine levels in serum and exhaled breath condensate according to the severit...
Table S6. Results from Ingenuity Pathway Analysis Suite Analysis of Biomarker data. (DOCX 18 kb
Panther-based classification of protein pathways comparing lung cancer markers identified in tissues...
Table S1. Quantile regression multivariable analysis of association between COL11A1 and COL10A1 leve...
Additional file 1: Table S1. Differentially expressed proteins identified in plasma samples
Table S1. Protein analyte concentrations for benralizumab- and placebo-treated patients with asthma ...
Demographics and clinical profiles for subjects selected for fresh tissue discovery study
Candidate lung cancer biomarkers (nâ=â179) identified through LC/MS analysis
Figure S1. COL11A and COL10A levels are not associated with overall survival. Kaplan Meier overall s...
Table S1. Serum biomarkers in 2005, comparing subjects participating respectively alive but not part...
Expression levels of biomarker candidates in serum collected from patients with NSCLC (nâ=â94) a...
Panther-based classification of protein class for candidate lung cancer markers (nâ=â179)
S1: baseline characteristics stratified by adverse events. S2-S3: Kaplan-Meier curves for OS and PFS...
Characteristics and differences by serum CYFRA 21-1 levels in patients with advanced-stage lung aden...
Table S2. Datasets of expression levels of complement proteins extracted from published publications...
Complete analysis of cytokine levels in serum and exhaled breath condensate according to the severit...
Table S6. Results from Ingenuity Pathway Analysis Suite Analysis of Biomarker data. (DOCX 18 kb
Panther-based classification of protein pathways comparing lung cancer markers identified in tissues...